Connect with us


Ethos Veterinary Health Acquired by National Veterinary Associates in $1.65B Deal

Ethos shareholders ‘will commit a significant portion of their investment into stock in NVA.’




National Veterinary Associates is acquiring Ethos Veterinary Health.

PE Hub reports that it’s a $1.65 billion deal.

Ethos’ management team, including CEO G. Ames Prentiss, will continue to lead Ethos’ community of specialty hospitals while supporting the organization’s clinical research and leading veterinary learning ecosystem, VetBloom.

As part of the transaction, Ethos shareholders “will commit a significant portion of their investment into stock in NVA,” according to a press release. In addition, NVA has announced a $10 million contribution to Ethos Discovery, a non-profit science and medical incubator designed to improve diagnostic and therapeutic treatment for complex medical conditions, including cancer research.

Founded in 2015 after the merger of four specialty veterinary groups, Ethos Veterinary Health operates 23 hospitals across the U.S., with over 400 veterinarians and about 1,900 employees.

NVA is a network of nearly 1,200 independently managed veterinary hospitals providing specialty, emergency and general medical care, along with more than 100 pet resorts. NVA Compassion-First is NVA’s specialty and emergency care group of more than 1,200 specialists and emergency doctors across 90 veterinary hospitals.


Greg Hartmann, CEO of NVA, said, “Ethos’ passion and commitment to transforming medicine through a diverse offering of clinical research and education programs create a compelling growth opportunity for our community. Our shared purpose promotes NVA’s vision to build the leading veterinary community rooted in compassion, innovation, and advanced medicine, enabling veterinary teams to offer best-in-class care to pets and their families.”

Prentiss, CEO of Ethos, added, “With a science-driven focus and shared passion for providing patients with unsurpassed veterinary healthcare, our two organizations uniquely complement one another. We look forward to working with NVA to continue advancing animal health as we execute on our multi-faceted growth strategy in the years to come.”

Read more at PE Hub




Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at

Promoted Headlines

Most Popular